These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15180647)

  • 1. A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
    Wein AJ
    BJU Int; 2004 Jun; 93(9):1361. PubMed ID: 15180647
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence.
    Wein AJ
    BJU Int; 2004 May; 93(7):1115. PubMed ID: 15142177
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
    Musselman DM; Ford AP; Gennevois DJ; Harbison ML; Laurent AL; Mokatrin AS; Stoltz RR; Blue DR
    BJU Int; 2004 Jan; 93(1):78-83. PubMed ID: 14678373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.
    Whitlock GA; Conlon K; McMurray G; Roberts LR; Stobie A; Thurlow RJ
    Bioorg Med Chem Lett; 2008 May; 18(9):2930-4. PubMed ID: 18400496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence.
    Blue DR; Daniels DV; Gever JR; Jett MF; O'Yang C; Tang HM; Williams TJ; Ford AP
    BJU Int; 2004 Jan; 93(1):162-70. PubMed ID: 14678390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function.
    Conlon K; Christy C; Westbrook S; Whitlock G; Roberts L; Stobie A; McMurray G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):892-901. PubMed ID: 19498105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A prospective control study on treatment of stress urinary incontinence with alpha-adrenoceptor agonists and pelvic floor muscle exercises].
    Zhu L; Lang JH; Hai N; Li Y; Xiao H
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):537-9. PubMed ID: 17083839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonists.
    Roberts LR; Bryans J; Conlon K; McMurray G; Stobie A; Whitlock GA
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6437-40. PubMed ID: 18980842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.
    Roberts LR; Fish PV; Ian Storer R; Whitlock GA
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3113-7. PubMed ID: 19414260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.
    Whitlock GA; Brennan PE; Roberts LR; Stobie A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3118-21. PubMed ID: 19394220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of urethral closure function in women with stress urinary incontinence.
    Klarskov N; Scholfield D; Soma K; Darekar A; Mills I; Lose G
    J Urol; 2009 Jun; 181(6):2628-33; discussion 2633. PubMed ID: 19375093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo-controlled, double-blind crossover study.
    Radley SC; Chapple CR; Bryan NP; Clarke DE; Craig DA
    Neurourol Urodyn; 2001; 20(1):43-52. PubMed ID: 11135381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Receptor pharmacology (3): Adrenoreceptor stimulants and blockaders in obstetrics, gynecology and urology].
    Andersson KE
    Lakartidningen; 1978 Nov; 75(44):4023-8. PubMed ID: 29999
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence.
    Yalcin I; Bump RC
    Am J Obstet Gynecol; 2004 Jul; 191(1):194-7. PubMed ID: 15295364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in nonoperative treatment of genuine stress incontinence.
    Sand PK; Brubaker LT
    Curr Opin Obstet Gynecol; 1990 Aug; 2(4):599-604. PubMed ID: 1983385
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of hormones on urinary incontinence in postmenopausal women.
    Quinn SD; Domoney C
    Climacteric; 2009 Apr; 12(2):106-13. PubMed ID: 19259853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test.
    Diernaes E; Rix P; Sørensen T; Alexander N
    Urol Int; 1989; 44(1):28-31. PubMed ID: 2568712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline.
    Shanler SD; Ondo AL
    Arch Dermatol; 2007 Nov; 143(11):1369-71. PubMed ID: 18025359
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.